Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alphatec Holdings (ATEC – Research Report), Vertex ...
https://www.tipranks.com/news/the-fly/lixte-biotechnology-announces-closing-of-1-05m-registered-direct-offering Scotiabank raised the firm’s price target on Vertex ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results